A241820 Stock Overview
Provides multiplex in vitro diagnostic (IVD) products and platform services.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
PCL, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩1,035.00 |
| 52 Week High | ₩4,725.00 |
| 52 Week Low | ₩951.00 |
| Beta | 0.012 |
| 11 Month Change | 0% |
| 3 Month Change | -32.84% |
| 1 Year Change | -57.87% |
| 33 Year Change | -94.94% |
| 5 Year Change | -61.52% |
| Change since IPO | -66.10% |
Recent News & Updates
Recent updates
Did You Miss PCL's (KOSDAQ:241820) Impressive 208% Share Price Gain?
Mar 16
Is PCL (KOSDAQ:241820) Using Too Much Debt?
Feb 17
PCL, Inc. (KOSDAQ:241820) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?
Jan 27We're Not So Sure You Should Rely on PCL's (KOSDAQ:241820) Statutory Earnings
Jan 06Is PCL's (KOSDAQ:241820) Share Price Gain Of 249% Well Earned?
Dec 16Do Institutions Own PCL, Inc. (KOSDAQ:241820) Shares?
Nov 25Shareholder Returns
| A241820 | KR Medical Equipment | KR Market | |
|---|---|---|---|
| 7D | 3.3% | -0.9% | -0.6% |
| 1Y | -57.9% | 12.3% | 6.8% |
Return vs Industry: A241820 underperformed the KR Medical Equipment industry which returned 14.9% over the past year.
Return vs Market: A241820 underperformed the KR Market which returned 5.7% over the past year.
Price Volatility
| A241820 volatility | |
|---|---|
| A241820 Average Weekly Movement | 7.2% |
| Medical Equipment Industry Average Movement | 5.6% |
| Market Average Movement | 5.0% |
| 10% most volatile stocks in KR Market | 11.1% |
| 10% least volatile stocks in KR Market | 2.4% |
Stable Share Price: A241820's share price has been volatile over the past 3 months.
Volatility Over Time: A241820's weekly volatility has decreased from 13% to 7% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | 35 | Soyeon Kim | www.pclchip.com |
PCL, Inc. provides multiplex in vitro diagnostic (IVD) products and platform services. The company offers multiplex antibody and antigen diagnostic kits for the detection of antibodies to human immunodeficiency virus (HIV) 1 and 2, HBV, hepatitis C virus (HCV), and human T-lymphotropic virus 1 and 2, as well as antigens to HIV p24, HCV core, and HBV surface in human serum or plasma. It also provides Ai, an influenza A/B typing rapid diagnostic test kit; Cancer6, a multiple tumor markers screening kit; and sciLINER LATERAL FLOW DISPENSER, a dispenser for membrane materials with active visual drop volume control.
PCL, Inc. Fundamentals Summary
| A241820 fundamental statistics | |
|---|---|
| Market cap | ₩56.47b |
| Earnings (TTM) | -₩16.70b |
| Revenue (TTM) | ₩8.10b |
6.9x
P/S Ratio-3.3x
P/E RatioIs A241820 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A241820 income statement (TTM) | |
|---|---|
| Revenue | ₩8.10b |
| Cost of Revenue | ₩11.80b |
| Gross Profit | -₩3.70b |
| Other Expenses | ₩13.00b |
| Earnings | -₩16.70b |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -309.00 |
| Gross Margin | -45.68% |
| Net Profit Margin | -206.24% |
| Debt/Equity Ratio | 38.3% |
How did A241820 perform over the long term?
See historical performance and comparison